Quality of Life in Survivors of Gynecologic Cancer
|ClinicalTrials.gov Identifier: NCT00003795|
Recruitment Status : Completed
First Posted : July 18, 2003
Last Update Posted : May 27, 2013
RATIONALE: Quality-of-life assessment in cancer survivors may help determine the long-term effects of having had gynecologic cancer and may help improve the quality of life for future cancer survivors.
PURPOSE: This clinical trial is studying the quality of life in survivors of gynecologic cancer.
|Condition or disease||Intervention/treatment|
|Endometrial Cancer Ovarian Cancer||Procedure: quality-of-life assessment|
- Describe the significant quality of life (QOL) concerns and long term survivorship issues of women diagnosed and treated for early stage ovarian and endometrial cancer five or more years ago.
- Identify mechanisms which contribute to a gynecologic cancer survivorship model through comparison and prediction of high versus low QOL associated with long term adjustment and survivorship. Examine social support, coping efforts, self-efficacy, meaning associated with survivorship, performance status, and age at diagnosis as potential predictors.
- Identify and compare factors that predict high versus low QOL for women with early stage endometrial cancer completing participation in GOG-99 clinical trial. Conduct exploratory analysis examining long term QOL concerns of survivors randomized to surgery arm with or without radiotherapy.
OUTLINE: Patients complete one telephone interview with a professional female interviewer. The interview lasts approximately 60 minutes and is audiotaped.
PROJECTED ACCRUAL: A total of 197 early stage endometrial cancer survivors and 114 early stage ovarian cancer survivors will be accrued for this study within 2 years.
|Study Type :||Observational|
|Estimated Enrollment :||311 participants|
|Official Title:||Quality of Life of Gynecologic Cancer Survivors|
|Study Start Date :||April 1999|
|Actual Primary Completion Date :||March 2002|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00003795
Show 44 Study Locations
|Study Chair:||Lari B. Wenzel, PhD||Chao Family Comprehensive Cancer Center|